Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jolanda Sarno

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nature Medicine|March 6, 2018
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapseZinaida Good, Jolanda Sarno, Astraea Jager, et al.
Oncotarget|May 26, 2018
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemiaJolanda Sarno, Angela M Savino, Chiara Buracchi, et al.
Haematologica|April 12, 2015
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemiaCristina Bugarin, Jolanda Sarno, Chiara Palmi, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALLYuxuan Liu, Haowen Jiang, Jingjing Liu, et al.
Nature Communications|February 4, 2022
An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemiaIfat Geron, Angela Maria Savino, Hila Fishman, et al.
Blood|January 23, 2026
DHODH as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALLYuxuan Liu, Haowen Jiang, Jingjing Liu, et al.
Journal of Translational Medicine|May 19, 2025
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalabilityIlaria Pisani, Giusi Melita, Patricia Borges de Souza, et al.
Nature Communications|April 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignanciesPablo Domizi, Jolanda Sarno, Astraea Jager, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature Medicine|March 6, 2018
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapseZinaida Good, Jolanda Sarno, Astraea Jager, et al.
Oncotarget|May 26, 2018
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemiaJolanda Sarno, Angela M Savino, Chiara Buracchi, et al.
Haematologica|April 12, 2015
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemiaCristina Bugarin, Jolanda Sarno, Chiara Palmi, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALLYuxuan Liu, Haowen Jiang, Jingjing Liu, et al.
Nature Communications|February 4, 2022
An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemiaIfat Geron, Angela Maria Savino, Hila Fishman, et al.
Blood|January 23, 2026
DHODH as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALLYuxuan Liu, Haowen Jiang, Jingjing Liu, et al.
Journal of Translational Medicine|May 19, 2025
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalabilityIlaria Pisani, Giusi Melita, Patricia Borges de Souza, et al.
Nature Communications|April 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignanciesPablo Domizi, Jolanda Sarno, Astraea Jager, et al.
Pageof 2